$BGNE BeiGene, Ltd. Insider Trading Week 33/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BeiGene, Ltd. in week 33/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 243.48 | 694 | 168,976 | 0 | 694 to 0 (-100.00 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.96 | 6,700 | 1,627,837 | 694 | 7.4 K to 694 (-90.61 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 241.62 | 2,471 | 597,033 | 7,394 | 9.9 K to 7.4 K (-25.05 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 240.64 | 6,255 | 1,505,215 | 9,865 | 16.1 K to 9.9 K (-38.80 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 239.66 | 10,997 | 2,635,540 | 16,120 | 27.1 K to 16.1 K (-40.55 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 238.86 | 10,568 | 2,524,293 | 27,117 | 37.7 K to 27.1 K (-28.04 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.80 | 3,103 | 737,882 | 37,685 | 40.8 K to 37.7 K (-7.61 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.44 | 4,679 | 1,110,972 | 0 | 4.7 K to 0 (-100.00 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 236.50 | 2,101 | 496,879 | 4,679 | 6.8 K to 4.7 K (-30.99 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 235.22 | 3,845 | 904,411 | 6,780 | 10.6 K to 6.8 K (-36.19 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.45 | 4,798 | 1,124,895 | 10,625 | 15.4 K to 10.6 K (-31.11 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 233.13 | 600 | 139,875 | 15,423 | 16 K to 15.4 K (-3.74 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.34 | 2,000 | 464,678 | 16,023 | 18 K to 16 K (-11.10 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 231.15 | 2,500 | 577,881 | 18,023 | 20.5 K to 18 K (-12.18 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 230.16 | 1,000 | 230,158 | 20,523 | 21.5 K to 20.5 K (-4.65 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.04 | 1,300 | 308,155 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 236.32 | 4,800 | 1,134,328 | 1,300 | 6.1 K to 1.3 K (-78.69 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 235.23 | 6,221 | 1,463,352 | 6,100 | 12.3 K to 6.1 K (-50.49 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.24 | 9,741 | 2,281,767 | 12,321 | 22.1 K to 12.3 K (-44.15 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 233.35 | 4,403 | 1,027,421 | 22,062 | 26.5 K to 22.1 K (-16.64 %) |
| Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.36 | 3,401 | 790,243 | 26,465 | 29.9 K to 26.5 K (-11.39 %) |
| Aug 20 2020 | BGNE | BeiGene, Ltd. | AMGEN INC | 10% Owner | Grant | A | 234.99 | 64,176 | 15,080,981 | 18,341,417 | 18.3 M to 18.3 M (+0.35 %) |
| Aug 20 2020 | BGNE | BeiGene, Ltd. | AMGEN INC | 10% Owner | Grant | A | 234.88 | 64,176 | 15,073,454 | 18,277,241 | 18.2 M to 18.3 M (+0.35 %) |
| Aug 20 2020 | BGNE | BeiGene, Ltd. | AMGEN INC | 10% Owner | Grant | A | 230.18 | 40,000 | 9,207,188 | 18,213,065 | 18.2 M to 18.2 M (+0.22 %) |